PRVA (Privia Health Group) EBITDA Margin %: 1.77% (As of Mar. 2026) — 16% Above Median


PRVA Privia Health Group Inc PRVA
85 GF Score
Price $25.73
GF Value $27.39
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Privia Health Group EBITDA Margin %?

Privia Health Group PRVA +0.67% 85 EBITDA Margin % is 1.77% as of Mar. 2026, which is 16% above its 10-year median of 1.52. GuruFocus rates PRVA with a GF Score™ of 85/100 and a GF Value™ of $27.39 (Fairly Valued). The stock has 6 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Privia Health Group ranks worse than 70.42% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Privia Health Group's EBITDA for the three months ended in Mar. 2026 was $11 Mil. Privia Health Group's Revenue for the three months ended in Mar. 2026 was $604 Mil. Therefore, Privia Health Group's EBITDA margin for the quarter that ended in Mar. 2026 was 1.77%.


Privia Health Group  (NAS:PRVA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Privia Health Group EBITDA Margin % Related Terms


Privia Health Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Privia Health Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Privia Health Group EBITDA Margin % Chart

Privia Health Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial -22.25 -1.07 1.64 1.40 2.08

Privia Health Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.48 1.14 2.96 2.57 1.77

PRVA vs HTFL, WAY, DOCS: EBITDA Margin % Comparison

For the Health Information Services subindustry, Privia Health Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Privia Health Group EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Privia Health Group's EBITDA Margin % falls into.


PRVA
85GF Score
Privia Health Group Inc PRVA
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Privia Health Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Privia Health Group's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=44.142/2122.842
=2.08 %

Privia Health Group's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=10.703/603.847
=1.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 1.77% mean?
Privia Health Group (PRVA) has a EBITDA Margin % of 1.77% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Privia Health Group and its competitors. This is 16% above median its historical median of 1.52. According to the industry distribution chart, Privia Health Group ranks #469 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 70.4%.
Is Privia Health Group's EBITDA Margin % too high?
Privia Health Group's current EBITDA Margin % of 1.77% is 16% above median its 10-year median of 1.52. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Privia Health Group's value of 1.77% is 82.7% below this industry median. Based on the distribution chart, Privia Health Group ranks #469 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Privia Health Group has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Privia Health Group's EBITDA Margin % compare to HTFL and WAY?
According to the Healthcare Providers & Services industry distribution chart, Privia Health Group ranks #469 out of 666 companies for EBITDA Margin %. This places Privia Health Group in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Privia Health Group's value of 1.77% is 82.7% below this benchmark. While the company's 10-year median is 1.52 vs. the industry median of 10.24, Privia Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Privia Health Group's current EBITDA Margin % of 1.77% is 82.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Privia Health Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Privia Health Group's current EBITDA Margin % is 1.77%, which is 16% above median its own 10-year median of 1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Privia Health Group stock overvalued right now?
Based on GuruFocus' analysis, Privia Health Group (PRVA) is currently considered Fairly Valued. The stock's GF Value™ is $27.39, compared to a current price of $25.73 — trading 6.1% below its estimated fair value. The current EBITDA Margin % is 1.77%, which is 16% above median its 10-year median of 1.52 and 82.7% below the Healthcare Providers & Services industry median of 10.24. Privia Health Group's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Privia Health Group (PRVA), the current EBITDA Margin % is 1.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Privia Health Group (PRVA) Overvalued in 2026?

Based on GuruFocus' analysis, Privia Health Group stock appears to be undervalued. The current stock price of $25.73 is trading 6.1% below its estimated GF Value™ of $27.39. GuruFocus considers Privia Health Group to be Fairly Valued.

Key valuation signals for PRVA:

  • EBITDA Margin %: 1.77% (16% above median its 10-year median of 1.52)
  • GF Value™: $27.39 vs. price of $25.73 (6.1% below fair value)
  • GF Score™: 85/100 with 6 warning signs
  • Industry Position: 82.7% below the Healthcare Providers & Services median (#469 of 666)

No single metric tells the full story. See the PRVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Privia Health Group Business Description

Address 950 North Glebe Road, Suite 700, Arlington, VA, USA, 22203
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
85GF Score

Get the complete analysis for PRVA

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.73
Price
$27.39
GF Value